Market Cap | 789.49M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | - | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 1.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -1.00% |
Dividend | N/A | Price/Book | EPS next 5Y | - | 52W High Chg | -11.00% | |
Recommedations | - | Quick Ratio | - | Shares Outstanding | 41.36M | 52W Low Chg | 8.00% |
Insider Own | 0.00% | ROA | - | Shares Float | - | Beta | - |
Inst Own | 20.76% | ROE | - | Shares Shorted/Prior | 17.78K/8.85K | Price | 19.09 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 87,296 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 97,286 | Change | -0.26% |
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Maher Bill | Director Director | Dec 28 | Buy | 18.25 | 1,000 | 18,250 | 1,000 | 01/02/24 |
Goetz Kathleen | Director Director | Mar 23 | Buy | 21.6850 | 69 | 1,500 | 548 | 03/24/22 |
Goetz Kathleen | Director Director | Jan 26 | Buy | 21.73 | 479 | 10,409 | 479 | 01/27/22 |